ABSTRACT
BACKGROUND: Axillary bromhidrosis is a common but unpleasant and distressing problem faced by many societies, particularly in Asia, where malodour is reflected as a social handicap. Currently, local surgery is the treatment of choice among various non-surgical and surgical treatment. OBJECTIVES: To evaluate the clinical efficacy and safety of tumescent superficial liposuction and curettage in treating axillary bromhidrosis. METHODS: Forty-three patients (25 females and 18 males, average age 24.5 years) have undergone tumescent superficial liposuction and curettage. Local anaesthesia, tumescent solution, was injected into the hair-bearing area of the axilla. Two tiny incisions were made for Fatemi cannule, and subcutaneous tissue was removed by stroke movement under negative pressure. Subsequently, additional curettage was done around the incision sites. We evaluated the clinical efficacy (excellent, good, fair and poor) and complications. In addition, preoperative and postoperative histologic findings were reviewed in 15 patients. RESULTS: The follow-up evaluation started 3 months after the surgery, and mean follow-up period was 15.8 months, ranging from 3 to 54 months. Among 43 patients, 31 patients (72.1%) showed excellent to good results. The most common postoperative complication was transient ecchymosis which spontaneously regressed in 1 to 2 weeks. Focal skin necrosis, induration, and haematoma or seroma were each noted in four, three, and one patients, respectively, but resolved after proper dressing. The preoperative histological findings included increase in size and number of apocrine glands in cross-section view, and the postoperative specimen evidently showed removal of subcutaneous tissue, including apocrine and eccrine glands, and remnant sweat glands were severely destructed. CONCLUSION: Tumescent superficial liposuction with curettage for axillary bromhidrosis is an effective and safe treatment method for axillary bromhidrosis.
Subject(s)
Axilla/surgery , Curettage/methods , Hyperhidrosis/surgery , Lipectomy/methods , Odorants/prevention & control , Adolescent , Adult , Apocrine Glands/microbiology , Apocrine Glands/physiopathology , Axilla/physiopathology , Child , Curettage/adverse effects , Female , Follow-Up Studies , Humans , Hyperhidrosis/physiopathology , Lipectomy/adverse effects , Male , Middle Aged , Prospective Studies , Treatment OutcomeSubject(s)
Lupus Erythematosus, Systemic/complications , Meningitis, Bacterial/microbiology , Streptococcal Infections/microbiology , Streptococcus agalactiae/isolation & purification , Adolescent , Diagnosis, Differential , Female , Humans , Lupus Erythematosus, Systemic/diagnosis , Meningitis, Bacterial/diagnosis , Meningitis, Bacterial/drug therapy , Streptococcal Infections/diagnosis , Streptococcal Infections/drug therapySubject(s)
Lichen Planus/diagnosis , Back , Diagnosis, Differential , Humans , Lichen Planus/pathology , Male , Middle Aged , NeckABSTRACT
A samarium 153-chitosan complex was prepared by simply mixing acidic solutions of chitosan and (153)SmCl(3). When a solution of this complex was injected into the knee joints of rabbits, minimal extra-articular leakage was observed. This can be attributed to the rapid change in the pH of the complex solution from acidic to neutral, resulting in the formation of gel followed by the subsequent retention in the administered site. Thus, the complex solution represents a promising candidate for radiation synovectomy.
Subject(s)
Chitin/chemical synthesis , Knee Joint/radiation effects , Radioisotopes/therapeutic use , Synovial Fluid/radiation effects , Animals , Chitin/analogs & derivatives , Chitin/pharmacokinetics , Chitin/therapeutic use , Chitosan , Knee Joint/metabolism , Male , Rabbits , Radioisotopes/pharmacokinetics , Tissue DistributionABSTRACT
An efficient procedure for the preparation of 4-hydroxy-3-{1,2,3,4-tetra-hydro-3-[4-(4-triflu-oromethylbenzyl oxy)phenyl]-1-naphthyl}thiocoumarin (thioflocoumafen, 1a and 1b) is described. The key step in the synthesis involves the condensation reaction of 3-(4-methoxyphenyl)-1-tetralol (2) with 4-hydroxy-1-thiocoumarin (3).